z-logo
open-access-imgOpen Access
Erythrodermic psoriasis improved by tildrakizumab
Author(s) -
Giampaolo Trevisan,
Lerica Germi,
Luigi Naldi
Publication year - 2022
Publication title -
dermatology reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.183
H-Index - 10
eISSN - 2036-7406
pISSN - 2036-7392
DOI - 10.4081/dr.2022.9448
Subject(s) - medicine , psoriasis , erythema , proinflammatory cytokine , dermatology , monoclonal , monoclonal antibody , immunology , antibody , inflammation

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom